-
In this issue: Anticholinergic drugs for COPD; pioglitazone for diabetes prevention; insulin degludec in Phase 3 trials; and FDA Actions.
-
-
-
-
-
This March, the industry once again celebrated National Patient Safety Awareness Week an apropos title as quality professionals have certainly become increasingly aware of the importance of patient safety in recent years. But how well have we done?
-
A study published recently in Health Affairs shows that hospitalization costs for patients with certain terminal or serious chronic illnesses are significantly lower when palliative care is provided.
-
Princeton Baptist Medical Center in Birmingham, AL, was recently chosen as one of two national HIMSS/ASQ Stories of Success for the 22% reduction in healthcare-associated infections (HAIs) resulting from their adoption of a radio frequency identification (RFID)-based hand-hygiene monitoring system.
-
Given that patients are keenly interested in wait times, an increasing number of EDs across the country are taking advantage of new media to make this information more accessible to the public.
-
Hospital ethics boards now can refer to national guidelines when developing procedural standards and processes for evaluating quality of ethics consultations (EC) and institutional EC processes.
